Form 4: ClearPoint Neuro Director Boosts Stake with Stock Grant

ClearPoint Neuro Director Timothy T. Richards acquired 884 shares of common stock as compensation, increasing his beneficial ownership to 79,754 shares.

Summary

• Timothy T. Richards, a Director of ClearPoint Neuro, Inc. (CLPT), acquired 884 shares of common stock.
• The transaction occurred on January 2, 2026.
• The shares were acquired at a price of $13.68 per share.
• This acquisition was made pursuant to the issuer's Sixth Amended and Restated 2013 Incentive Compensation Plan.
• The shares were issued in payment of fees owed to Mr. Richards under the issuer's Non-Employee Director Compensation Plan, as amended and restated.
• The shares' value was determined by the closing price of the issuer's common stock on December 31, 2025.
• Following this transaction, Mr. Richards beneficially owns a total of 79,754 shares of ClearPoint Neuro common stock.

Sentiment

Score: 6

Explanation: Slightly positive. A director receiving shares as compensation is a routine event, but it does increase their personal stake in the company, which can be viewed favorably as it aligns their interests with shareholders. No negative implications are present.

Positives

• A director increasing their beneficial ownership, even through compensation, can signal alignment of interests with shareholders.
• The transaction was executed under a pre-existing, approved compensation plan, indicating structured corporate governance.

Future Outlook

This filing does not contain specific forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This routine insider transaction reflects a standard compensation practice for non-employee directors within publicly traded companies, aligning director interests with long-term shareholder value. It does not provide broader insights into industry trends or competitive positioning.

Comparison to Industry Standards

• The practice of compensating non-employee directors with equity is a common and widely accepted corporate governance standard across various industries, including the medical technology sector where ClearPoint Neuro operates.
• Many companies, such as Medtronic plc or Stryker Corporation, utilize similar equity-based compensation plans to incentivize directors and align their financial interests with company performance and shareholder returns.

Corporate Governance

Related Party Transactions

• The acquisition of shares by Director Timothy T. Richards as payment for fees constitutes a related party transaction, as it involves compensation from the company to a member of its board of directors under established compensation plans.

Stakeholder Impact

• Shareholders: Increased ownership by a director may be viewed positively as it aligns management interests with shareholder returns.
• Employees: No direct impact mentioned in this filing.
• Customers: No direct impact mentioned in this filing.
• Suppliers: No direct impact mentioned in this filing.
• Creditors: No direct impact mentioned in this filing.

Key Dates

Keywords

ClearPoint Neuro, CLPT, Timothy T. Richards, Director, Insider Transaction, Form 4, Stock Acquisition, Compensation Plan, Equity Grant